Recent Finacing
Recent Raise
Agios Pharmaceuticals develops therapeutics and diagnostics targeting cancer metabolism—using integrated metabolomics, genetics, biochemistry and bioinformatics to identify/validate metabolic targets (notably mutant IDH1 and 2‑HG) and apply platforms to IEMs.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors